MAIA Biotechnology, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- MAIA Biotechnology, Inc. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $3.66M, a 513.80% increase year-over-year.
- MAIA Biotechnology, Inc. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $1.42M, a 79.13% decline year-over-year.
- MAIA Biotechnology, Inc. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $1.39M, a 145.90% increase year-over-year.
- MAIA Biotechnology, Inc. stock issued during period, value, new issues for the quarter ending 2024-09-30 was $596.63K.
- MAIA Biotechnology, Inc. stock issued during period, value, new issues for fiscal 2025 was $6.87M, a 27.28% decline from fiscal 2024.
- MAIA Biotechnology, Inc. stock issued during period, value, new issues for fiscal 2024 was $9.45M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $6.87M 10-K · filed 2026-03-23 | |
| 2025-09-30 | $3.66M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $1.42M 10-Q · filed 2026-08-10 | |
| 2025-03-31 | $1.39M 10-Q · filed 2026-08-10 | |
| 2024-12-31 | $9.45M 10-K · filed 2026-03-23 | |
| 2024-09-30 | $596.63K 10-Q · filed 2025-11-07 | |
| 2024-06-30 | $6.80M 10-Q · filed 2025-11-07 | |
| 2024-03-31 | $565.62K 10-Q · filed 2025-11-07 | |
| 2023-06-30 | $4.16M 10-Q · filed 2023-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |